睿创微纳(688002) - 2021 Q1 - 季度财报

Financial Performance - Operating income for the first quarter reached CNY 380,597,510.22, a 64.94% increase year-on-year [5]. - Net profit attributable to shareholders was CNY 95,812,770.36, reflecting a 12.68% increase from the same period last year [4]. - Basic earnings per share rose by 12.67% to CNY 0.2153 [4]. - Total operating revenue for Q1 2021 reached RMB 380,597,510.22, a 64.94% increase compared to RMB 230,744,131.53 in Q1 2020 [14]. - The company's total comprehensive income for Q1 2021 was ¥95,514,175.15, compared to ¥85,062,952.74 in Q1 2020, reflecting an increase of approximately 12% [25]. - The company reported a total profit of ¥107,311,500.91 for Q1 2021, compared to ¥96,695,987.27 in Q1 2020, an increase of about 11% [25]. Cash Flow - The net cash flow from operating activities surged by 196.09% to CNY 60,999,162.07 compared to the previous year [4]. - Cash inflow from operating activities totaled ¥383,318,436.58, compared to ¥267,846,813.88 in Q1 2020, indicating an increase of about 43.1% [31]. - The net cash flow from investment activities was -¥428,309,262.34, worsening from -¥76,425,063.21 in the same quarter last year [31]. - Cash outflow from investment activities was ¥572,382,659.60, compared to ¥86,526,041.84 in Q1 2020, showing a substantial increase in investment expenditures [31]. - The total cash and cash equivalents at the end of Q1 2021 were ¥831,396,045.35, down from ¥1,468,249,225.46 at the end of Q1 2020 [32]. Assets and Liabilities - Total assets increased by 4.71% to CNY 3,711,381,439.18 compared to the end of the previous year [4]. - The company's cash and cash equivalents decreased to approximately RMB 872 million from RMB 1.24 billion, representing a decline of about 29.8% [19]. - Total liabilities amounted to ¥609,718,381.64, down from ¥614,810,188.85, a decrease of about 0.15% [21]. - The total current liabilities increased to ¥100,070,993.37 from ¥46,159,845.40, a significant rise of approximately 116.5% [23]. - The total current assets were reported at approximately ¥1.47 billion, with no changes noted [41]. Research and Development - Research and development expenses accounted for 22.01% of operating income, up 9.42 percentage points year-on-year [5]. - The company's research and development expenses increased by 188.49% to RMB 83,777,760.41 from RMB 29,039,927.82 in the same period last year [14]. - Research and development expenses surged to ¥83,777,760.41 in Q1 2021, a significant increase of 188% from ¥29,039,927.82 in Q1 2020 [24]. Market and Growth Strategy - The company plans to continue expanding its market presence and investing in new technologies to drive future growth [14]. - The company is actively pursuing market expansion and new product development strategies, although specific details were not disclosed in the report [17]. Shareholder Information - The company reported a total of 11,040 shareholders at the end of the reporting period [8]. - Shareholders' equity increased to ¥3,101,663,057.54 from ¥2,929,765,403.89, marking a growth of approximately 5.9% [21]. Other Financial Metrics - The weighted average return on net assets decreased by 0.35 percentage points to 3.22% [4]. - The company has ongoing litigation involving a patent dispute with a claimed amount of approximately RMB 44.23 million, which may impact future profits [18]. - The company has reported no significant changes in its net profit forecast for the year, indicating stability in its financial outlook [18].